Bolder Biotechnology Inc
CAGE Code: 1PUB8
NCAGE Code: 1PUB8
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 004603163
Summary
Bolder Biotechnology Inc is an Active Commercial Supplier with the Cage Code 1PUB8 and is tracked by Dun & Bradstreet under DUNS Number 004603163..
Address
907 Pikes Peak Ln
Louisville CO 80027-3109
United States
Points of Contact
- Telephone:
- 3034204420
- Fax:
- 3034204426
-
http://www.bolderbio.com/
Related Information
People who viewed this 'CAGE Code' also viewed...
Carroll-Kron Consulting Inc. Ashley Gallery Inc Sisson Construction Company Inc Maxoptix Corporation Crowe Chizek And Company Llc Mcghee Tyson Inn Timely Tidy Tile Inc Test And Controls International Inc. Mission Data, Llc Urethane Spray Applications Inc North American Seating Co Inc Aviation Technology Inc National Lighting Standards Bradley And Sons Restaurant Hood Robbins Machine And Welding Service Thomas Dave Co The Insight Communications Co Lp National Printing Ink Co Smith Distributing Co Mh Equipment Corporation
Frequently Asked Questions (FAQ) for CAGE 1PUB8
- What is CAGE Code 1PUB8?
- 1PUB8 is the unique identifier used by NATO Organizations to reference the physical entity known as Bolder Biotechnology Inc located at 907 Pikes Peak Ln, Louisville CO 80027-3109, United States.
- Who is CAGE Code 1PUB8?
- 1PUB8 refers to Bolder Biotechnology Inc located at 907 Pikes Peak Ln, Louisville CO 80027-3109, United States.
- Where is CAGE Code 1PUB8 Located?
- CAGE Code 1PUB8 is located in Louisville, CO, USA.
Contracting History for CAGE 1PUB8 Most Recent 25 Records
- 75N93023C00011
- Advanced Development Of Bbt-059 As A Radiation Medical Countermeasure For Dosing Up To 48H Post Exposure"
- 14 Aug 2023
- Advanced Development Of Bbt-059 As A Radiation Medical Countermeasure For Dosing Up To 48H Post Exposure"
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $1,650,819.00
- Department Of Health And Human Services (Hhs)
- 75N93023C00011
- Advanced Development Of Bbt-059 As A Radiation Medical Countermeasure For Dosing Up To 48H Post Exposure"
- 29 Jun 2023
- Advanced Development Of Bbt-059 As A Radiation Medical Countermeasure For Dosing Up To 48H Post Exposure"
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $1,650,819.00
- Department Of Health And Human Services (Hhs)
- W81XWH21P0089
- Award Of Bolder Biotechnology's Dha Sbir Phase I Medical R&D Purchase Order For "Evaluating Bbt-059 As A Medical Countermeasure To Protect Against Hematopoietic Acute Radiation Syndrome"
- 20 Aug 2021
- Award Of Bolder Biotechnology's Dha Sbir Phase I Medical R&D Purchase Order For "Evaluating Bbt-059 As A Medical Countermeasure To Protect Against Hematopoietic Acute Radiation Syndrome"
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $249,876.75
- Department Of Defense (Dod)